Alexandria, VA –AASLD proudly announces the distinguished leadership of Dr. Ray Kim as its 2024 President. Dr. Kim, a renowned hepatologist and esteemed global researcher, assumed the role of President on January 1, bringing his wealth of experience and commitment to advancing liver disease research, education, and improved patient care.
W. Ray Kim, MD, MBA, FAASLD currently serves as Professor of Medicine and Chief, Division of Gastroenterology and Hepatology in the Department of Medicine at Standford University. As a key figure in the field of hepatology, Dr. Kim has been actively involved with AASLD for many years, contributing to the Association’s mission to prevent and cure liver disease. His dedication to the well-being of patients, coupled with his groundbreaking research, positions him as a leader at the forefront of innovations and advancements.
“I am thrilled to embark on a transformative year in hepatology as AASLD’s 74th President. It’s an honor and privilege to guide this esteemed organization towards new and expanded horizons in liver disease prevention and cure,” says Dr. Kim.
Under Dr. Kim's presidency, AASLD will continue to focus on developing diversity, equity, and inclusion among professionals in the field, promoting innovative research, and advocating for policies that enhance liver health worldwide. Dr. Kim’s vision aims to further establish AASLD as a global leader in liver disease research and patient care.
AASLD looks forward to a promising future under Dr. Kim’s presidency as his wealth of experience, passion for advancements, and collaborative approaches make him an ideal leader to guide AASLD in the evolving needs of both healthcare professionals and patients. Dr. Kim adds, “Let us seize the opportunity to innovate, collaborate, and make lasting contributions to the field.
For more information about AASLD and /or inquiries or interview requests, please contact: media@aasld.org.
About the AASLD
AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease. We foster research that leads to improved treatment options for millions of liver disease patients. We advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies.
##